Sinopharm Group Co. Ltd. | Income Statement
Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
210,538
251,871
282,064
301,905
320,232
408,075
Cost of Goods Sold (COGS) incl. D&A
194,342
232,174
259,988
278,766
294,633
372,373
Gross Income
16,196
19,697
22,075
23,139
25,599
35,702
SG&A Expense
8,726
9,975
10,994
11,523
12,284
17,532
EBIT
7,421
9,676
-
11,616
13,315
18,170
Unusual Expense
80
19
30
14
108
369
Non Operating Income/Expense
409
248
88
476
700
511
Interest Expense
2,315
2,916
2,730
2,580
3,273
5,459
Pretax Income
5,655
7,264
9,009
10,157
11,221
13,461
Income Tax
1,313
1,741
2,132
2,376
2,658
3,321
Equity in Affiliates
175
205
204
271
509
999
Consolidated Net Income
4,517
5,728
7,081
8,038
9,069
11,136
Net Income
2,839
3,618
4,653
5,416
6,088
6,910
Net Income After Extraordinaries
2,839
3,618
4,653
5,416
6,088
6,910
Net Income Available to Common
2,839
3,618
4,653
5,416
6,088
6,910
EPS (Basic)
1.12
1.40
1.68
1.96
2.20
2.33
Basic Shares Outstanding
2,523
2,585
2,767
2,760
2,761
2,968
EPS (Diluted)
1.13
1.40
1.68
1.96
2.20
2.33
Diluted Shares Outstanding
2,523
2,585
2,767
2,767
2,767
2,972
EBITDA
8,226
10,681
12,250
12,789
14,445
19,771
Other Operating Expense
49
46
-
-
-
-
Non-Operating Interest Income
220
236
300
340
370
608
Minority Interest Expense
1,678
2,110
2,428
2,622
2,981
4,227
Other After Tax Income (Expense)
-
-
-
14
4
3
About Sinopharm Group Co.
View Profile
